实用临床医药杂志
實用臨床醫藥雜誌
실용림상의약잡지
JOURNAL OF JIANGSU CLINICAL MEDICINE
2014年
13期
116-118
,共3页
朱西平%喻永龙%胡舰%胡守友
硃西平%喻永龍%鬍艦%鬍守友
주서평%유영룡%호함%호수우
奥沙利铂%神经毒性%甲钴胺%谷胱甘肽%预防
奧沙利鉑%神經毒性%甲鈷胺%穀胱甘肽%預防
오사리박%신경독성%갑고알%곡광감태%예방
oxaliplatin%neurotoxicity%mecobalamin%glutathione%precaution
目的:评估甲钴胺和还原性谷胱甘肽对减少奥沙利铂(L-OHP)引起的神经毒性的作用。方法采用随机、安慰剂对照的方法,将接受含有 L-OHP 和氟尿嘧啶(5-Fu)方案化疗的96例大肠癌患者随机分为对照组、甲钴胺组、还原性谷胱甘肽组,分别同时给予生理盐水、甲钴胺和还原性谷胱甘肽,利用奥沙利铂专用神经毒性分级和神经症状评分(NSS)指标观察患者神经毒性发生率及严重程度。结果对照组、甲钴胺组、还原性谷胱甘肽组急性神经毒性分别:28例(90.3%)、14例(46.7%)、19例(59.4%)。化疗3周期和6周期时,甲钴胺组神经毒性Ⅱ~Ⅲ度发生率显著低于对照组(P <0.01,P <0.05),而还原性谷胱甘肽组神经毒性Ⅱ~Ⅲ度发生率低于与对照组,但无显著性差异(P >0.05),甲钴胺组神经毒性Ⅱ~Ⅲ度发生率低于还原性谷胱甘肽组,但无显著性差异(P >0.05)。化疗3周期和6周期时,甲钴胺组 NSS 评分显著均低于对照组和还原性谷胱甘肽组(P <0.05或 P <0.01),而还原性谷胱甘肽组均与对照组无显著性差异(P >0.05)。结论甲钴胺能预防 L-OHP 神经毒性的发生率和程度。
目的:評估甲鈷胺和還原性穀胱甘肽對減少奧沙利鉑(L-OHP)引起的神經毒性的作用。方法採用隨機、安慰劑對照的方法,將接受含有 L-OHP 和氟尿嘧啶(5-Fu)方案化療的96例大腸癌患者隨機分為對照組、甲鈷胺組、還原性穀胱甘肽組,分彆同時給予生理鹽水、甲鈷胺和還原性穀胱甘肽,利用奧沙利鉑專用神經毒性分級和神經癥狀評分(NSS)指標觀察患者神經毒性髮生率及嚴重程度。結果對照組、甲鈷胺組、還原性穀胱甘肽組急性神經毒性分彆:28例(90.3%)、14例(46.7%)、19例(59.4%)。化療3週期和6週期時,甲鈷胺組神經毒性Ⅱ~Ⅲ度髮生率顯著低于對照組(P <0.01,P <0.05),而還原性穀胱甘肽組神經毒性Ⅱ~Ⅲ度髮生率低于與對照組,但無顯著性差異(P >0.05),甲鈷胺組神經毒性Ⅱ~Ⅲ度髮生率低于還原性穀胱甘肽組,但無顯著性差異(P >0.05)。化療3週期和6週期時,甲鈷胺組 NSS 評分顯著均低于對照組和還原性穀胱甘肽組(P <0.05或 P <0.01),而還原性穀胱甘肽組均與對照組無顯著性差異(P >0.05)。結論甲鈷胺能預防 L-OHP 神經毒性的髮生率和程度。
목적:평고갑고알화환원성곡광감태대감소오사리박(L-OHP)인기적신경독성적작용。방법채용수궤、안위제대조적방법,장접수함유 L-OHP 화불뇨밀정(5-Fu)방안화료적96례대장암환자수궤분위대조조、갑고알조、환원성곡광감태조,분별동시급여생리염수、갑고알화환원성곡광감태,이용오사리박전용신경독성분급화신경증상평분(NSS)지표관찰환자신경독성발생솔급엄중정도。결과대조조、갑고알조、환원성곡광감태조급성신경독성분별:28례(90.3%)、14례(46.7%)、19례(59.4%)。화료3주기화6주기시,갑고알조신경독성Ⅱ~Ⅲ도발생솔현저저우대조조(P <0.01,P <0.05),이환원성곡광감태조신경독성Ⅱ~Ⅲ도발생솔저우여대조조,단무현저성차이(P >0.05),갑고알조신경독성Ⅱ~Ⅲ도발생솔저우환원성곡광감태조,단무현저성차이(P >0.05)。화료3주기화6주기시,갑고알조 NSS 평분현저균저우대조조화환원성곡광감태조(P <0.05혹 P <0.01),이환원성곡광감태조균여대조조무현저성차이(P >0.05)。결론갑고알능예방 L-OHP 신경독성적발생솔화정도。
Objective To assess the efficacy of mecobalamin and glutathione in preventing the neurotoxicity induced by oxaliplatin (L-OHP).Methods A randomized,placebo and control study was made ,in which 9 6 patients with colorectal cancer received L-OHP and 5-Fluorouracil (5-FU)was randomly divided into control group treated with normal saline,mecobalamin group with mecobalamin and glutathione group with glutathione,respectively,32 cases for each.Rate of neurotoxicity and severity was observed by L-OHP-specific neurotoxicity grading and neurological symptom score (NSS).Results Rates of neurotoxicity in control group,mecobalamin group and glutathione group were 90.3%(28 /32),46.7%(14 /32)and 59.4%(19 /32)respectively.After 3-cycle and 6-cycle chemotherapy,the rate of neurotoxicity in degree Ⅱ~Ⅲ was lower in mecobal-amin group than in other groups,but the differences were not significant (P >0.05),whereas NSS score was obviously lower in mecobalamin group than in other groups (P <0.05,P <0.01),but the difference between control group and glutathione group was not significant (P >0.05).Conclu-sion Mecobalamin can prevent the rate and severity of oxaliplatin-induced neurotoxicity.